Twenty four-week peginterferon plus ribavirin after interferon-&beta; induction for genotype 1b chronic hepatitis C

doi:10.4254/wjh.v2.i6.226

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3661)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-4) series.

Item

Count

PDF

252

HTML

2996

Figures (1-3)

205

Tables (1-4)

208

Sum=3661

Jun 27, 2010 (publication date) through Aug 25, 2024

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Articles

World J Hepatol. Jun 27, 2010; 2(6): 226-232
Published online Jun 27, 2010. doi: 10.4254/wjh.v2.i6.226

Full Size Figure Download Figure

Figure 2 The SVR rate and 95% confidence interval (95% CI) by dosing duration of peginterferon (Peg-IFN) plus ribavirin (RBV) after interferon-β induction therapy. The significance of the difference was evaluated employing Fisher’s exact test.

Citation: Okushin H, Morii K, Uesaka K, Yuasa S. Twenty four-week peginterferon plus ribavirin after interferon-β induction for genotype 1b chronic hepatitis C. World J Hepatol 2010; 2(6): 226-232
URL: https://www.wjgnet.com/1948-5182/full/v2/i6/226.htm
DOI: https://dx.doi.org/10.4254/wjh.v2.i6.226